$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| IMFINZI APPROVED IN US FOR RESECTABLE LUNG CANCER | 16 Aug 2024 |
| TOTAL VOTING RIGHTS | 01 Aug 2024 |
| ASTRAZENECA PRICES A EUR1.4BN BOND OFFERING | 30 Jul 2024 |
| CALQUENCE FIXED-DURATION COMBO IMPROVED 1L CLL PFS | 29 Jul 2024 |
| ODAC REVIEWED IMFINZI IN RESECTABLE LUNG CANCER | 26 Jul 2024 |
| FORM 6K | 25 Jul 2024 |
| ACQUISITION OF AMOLYT PHARMA COMPLETED | 15 Jul 2024 |
| TOTAL VOTING RIGHTS | 01 Jul 2024 |
| LYNPARZA & IMFINZI POSITIVE CHMP IN ENDOMETRIAL | 01 Jul 2024 |
| ANNUAL REPORT | 26 Jun 2024 |
| UPDATE ON IMFINZI ADJUVANT BR.31 TRIAL | 25 Jun 2024 |
| IMFINZI IMPROVED EFS AND OS IN BLADDER CANCER | 25 Jun 2024 |
| UPDATE ON CAPITELLO-290 PHASE III TRIAL | 18 Jun 2024 |
| IMFINZI APPROVED IN THE US FOR ENDOMETRIAL CANCER | 17 Jun 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 12 Jun 2024 |
| 25-NSE | 04 Jun 2024 |
| FORM 6-K | 04 Jun 2024 |
| TOTAL VOTING RIGHTS | 03 Jun 2024 |
| BLOCK LISTING INTERIM REVIEW | 03 Jun 2024 |
| TAGRISSO PLUS CHEMO RECOMMENDED FOR APPROVAL IN EU | 03 Jun 2024 |
